Regnante Keith Insider Trades

Insider Trading History

Track insider trading activity for Regnante Keith. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Keros Therapeutics
Keros Therapeutics KROS
CHIEF FINANCIAL OFFICER
Holding Value $630k 60,000 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$931k 60,000 shares
$15.52
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF FINANCIAL OFFICER
Holding Value $412k 39,261 shares
Last Trade
Feb 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.5k 4,739 shares
$16.35
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF FINANCIAL OFFICER
Holding Value $462k 44,000 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 44,000 shares
$10.56
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF FINANCIAL OFFICER
Holding Value $420k 40,000 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.25M 40,000 shares
$56.18
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Jan 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.81M 40,000 shares
$45.29
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $563k 53,622 shares
Last Trade
Jan 04, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.96M 40,000 shares
$48.88
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF FINANCIAL OFFICER
Holding Value $420k 40,000 shares
Last Trade
Jan 04, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.96M 40,000 shares
$48.88
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $420k 40,000 shares
Last Trade
Nov 04, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.28M 40,000 shares
$31.94
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.28M 40,000 shares
$31.94
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $210k 20,000 shares
Last Trade
Jun 09, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$878k 20,000 shares
$43.89
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $983k 93,622 shares
Last Trade
Jun 09, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$878k 20,000 shares
$43.89
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $42.1k 4,007 shares
Last Trade
Jun 09, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$908k 20,000 shares
$45.42
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $28.3k 2,699 shares
Last Trade
Jun 08, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$956k 20,000 shares
$47.79
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $1.19M 113,622 shares
Last Trade
Jun 08, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$979k 20,000 shares
$48.96
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $420k 40,000 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 40,000 shares
$54.38
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $525k 50,000 shares
Last Trade
Jan 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.32M 50,000 shares
$46.30
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $516k 49,150 shares
Last Trade
Jan 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.49M 49,150 shares
$70.93
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Financial Officer
Holding Value $1.4M 133,622 shares
Last Trade
Apr 07, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$10.50
Wave Life Sciences
Wave Life Sciences WVE
Chief Financial Officer
Holding Value $168k 29,186 shares
Last Trade
Mar 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$608k 13,500 shares
$45.00
$5.76
Wave Life Sciences
Wave Life Sciences WVE
Chief Financial Officer
Holding Value $90.4k 15,686 shares
Last Trade
Feb 19, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.8k 1,298 shares
$36.84
$5.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up